Muhammad A. Budiman - Manchester MO, US Jeffrey A. Jeddeloh - Oakville MO, US Rebecca Maloney - Centreville VA, US Yulia Korshunova - Clayton MO, US
Assignee:
Orion Genomics LLC - St. Louis MO
International Classification:
C12Q 1/68 G06F 19/00
US Classification:
435 6, 702 20
Abstract:
The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with endometrial cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of endometrial cancer.
Muhammad A. Budiman - Manchester MO, US Jeffrey A. Jeddeloh - Oakville MO, US Rebecca Maloney - Centreville VA, US Yulia Korshunova - Clayton MO, US
Assignee:
Orion Genomics LLC - St. Louis MO
International Classification:
C12Q 1/68
US Classification:
435 6, 702 20
Abstract:
The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with ovarian cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of ovarian cancer.
Muhammad A. Budiman - Manchester MO, US Jeffrey A. Jeddeloh - Oakville MO, US Rebecca Maloney - Centerville VA, US Yulia Korshunova - Clayton MO, US
Assignee:
Orion Genomics LLC - St. Louis MO
International Classification:
C12Q 1/68
US Classification:
435 6, 702 20
Abstract:
The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with liver cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of liver cancer.
MUHAMMAD A. BUDIMAN - MANCHESTER MO, US JEFFREY A. JEDDELOH - OAKVILLE MO, US REBECCA MALONEY - CENTREVILLE VA, US YULIA KORSHUNOVA - CLAYTON MO, US
Assignee:
Orion Genomics LLC - ST. LOUIS MO
International Classification:
C12Q 1/68
US Classification:
435 6, 702 20
Abstract:
The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with thyroid cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of thyroid cancer.
Muhammad A. Budiman - Manchester MO, US Jeffrey A. Jeddeloh - Oakville MO, US Rebecca Maloney - Centreville VA, US Yulia Korshunova - Clayton MO, US
Assignee:
Orion Genomics LLC - St. Louis MO
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with colon cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of colon cancer.
MUHAMMAD A. BUDIMAN - MANCHESTER MO, US JEFFREY A. JEDDELOH - OAKVILLE MO, US REBECCA MALONEY - CENTREVILLE VA, US YULIA KORSHUNOVA - CLAYTON MO, US
Assignee:
ORION GENOMICS LLC - ST. LOUIS MO
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with lung cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of lung cancer.
Muhammad A. Budiman - Manchester MO, US Jeffrey A. Jeddeloh - Oakville MO, US Rebecca Maloney - Centreville VA, US Yulia Korshunova - Clayton MO, US
Assignee:
Orion Genomics LLC - St. Louis MO
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with bladder cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of bladder cancer.
Muhammad A. Budiman - Manchester MO, US Jeffrey A. Jeddeloh - Oakville MO, US Rebecca Maloney - Centreville VA, US Yulia Korshunova - Clayton MO, US
Assignee:
Orion Genomics LLC - St. Louis MO
International Classification:
C12Q 1/68 G01N 33/48
US Classification:
435 6, 702 19
Abstract:
The present invention provides DNA biomarker sequences that are differentially methylated in samples from normal individuals and individuals with renal cancer. The invention further provides methods of identifying differentially methylated DNA biomarker sequences and their use the detection and diagnosis of renal cancer.
SR.Mechanical Reliability Engineer at Conocophilips
Location:
Other
Industry:
Oil & Energy
Work:
Conocophilips - Asia pacific since Jul 2011
SR.Mechanical Reliability Engineer
RasGas - Qatar, Oil and Gas Jun 2006 - Jul 2011
Machinery & Reliability
RasGas, Qatar - qatar, middle east 2006 - 2011
M&R
Energy Jul 2004 - Dec 2005
Field Services engineer
Mobil oil - Oil and Gas Jan 1999 - Sep 2004
Machinery&Condition monitoring Engineer
Education:
Institute of technologi UNMA
B.SC, Mechanical engineering
UNSYIAH 1997 - 1999
Bachelor's degree, mechanical engineering
CERTIFIED FOR LEVEL II Vibration machinery diagnostic, BINDT
NDT, Vibration analysis level II
INSTITUTE OF INFRA RED TECHNOLOGY
Certified for level I, II, THERMOGRAPHY
Universitas Indonesia (UI)
Master Degree, Mechanical engineer
Orion Genomics
Senior Scientist, Team Leader - Tissue Core
Senior Scientist, Team Leader
Education:
Texas A&M University 1994 - 1999
Doctorates, Doctor of Philosophy, Biotechnology
Texas A&M University 1990 - 1994
Bachelors, Bachelor of Science, Botany